Thiotepa
3 clinical trials
1 abstract
4 indications
Indication
Sickle Cell DiseaseIndication
Graft-Versus-Host DiseaseIndication
Peripheral T Cell LymphomaIndication
Large B-Cell LymphomaAbstract
A multicenter cooperative group study of late effects after high-risk neuroblastoma: COG ALTE15N2—LEAHRN study.Org: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, St. Jude Children's Research Hospital, Children's Oncology Group Statistics and Data Center, University of Florida, Children's Hospital Los Angeles Department of Pediatrics,
Clinical trial
Abatacept for Graft Versus Host Disease Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease: a Sickle Transplant Alliance for Research TrialStatus: Completed, Estimated PCD: 2021-12-30
Clinical trial
Reduced Intensity Conditioning With Thiotepa Combined With Busulfan, Fludarabine and Cytarabine in Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma.Status: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
An Open-label, Multicenter, Multi-cohort Clinical Study of Linperlisib Combined With Standard Immunochemotherapy in the Treatment of Relapsed/Refractory Large B-Cell Lymphoma Failing to First-line TherapyStatus: Recruiting, Estimated PCD: 2026-12-31